LAURA LUDLOW: Open Payments
NPI 1154301802 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,741 in 131 payments from 15 companies in 2025. Trend: 2023 $15,840 · 2024 $12,949 · 2025 $25,741
Speaker / faculty: $16,071Travel & lodging: $4,585Food & beverage: $2,840Consulting: $2,244
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 72 | $21,186 |
| Regeneron Pharmaceuticals, Inc. | 2 | $1,344 |
| GlaxoSmithKline, LLC. | 14 | $1,210 |
| GENZYME CORPORATION | 8 | $1,170 |
| AstraZeneca Pharmaceuticals LP | 17 | $415 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $108 |
| Insmed, Inc. | 4 | $82 |
| Grifols USA, LLC | 2 | $47 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
Products named: DUPIXENT, NUCALA, FASENRA, LUMRYZ, Arikayce, TRELEGY ELLIPTA, Prolastin-C Liquid, TEZSPIRE.
Industry payments across CO — which companies pay providers there.
